MeiraGTx Holdings (MGTX) EPS (Weighted Average and Diluted) Growth (1y) (2021 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -82.39% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -97.49% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -79.34% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 61.45% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -7.15% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,178.57% |
| 10 | MeiraGTx Holdings | 856.58 Mn | 790.65 Mn | 74.89 Mn | 138.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 138.00% |
| Sep 30, 2025 | -12.73% |
| Jun 30, 2025 | 36.84% |
| Mar 31, 2025 | -59.38% |
| Dec 31, 2024 | -219.05% |
| Sep 30, 2024 | 25.68% |
| Jun 30, 2024 | -43.40% |
| Mar 31, 2024 | 48.39% |
| Dec 31, 2023 | 172.41% |
| Sep 30, 2023 | 10.84% |
| Jun 30, 2023 | 30.26% |
| Mar 31, 2023 | 11.43% |
| Dec 31, 2022 | -163.64% |
| Sep 30, 2022 | -40.68% |
| Jun 30, 2022 | -65.22% |
| Mar 31, 2022 | -29.63% |
| Dec 31, 2021 | 12.00% |
| Sep 30, 2021 | -247.06% |